Both nanovaccines co‐delivering Adpgk neoantigens and immune potentiators, despite NP composition, reduced the tumor growth rate when compared to the phosphate buffered saline (PBS)‐treated group, presenting significantly lower average tumor volumes (p < 0.05) (Figure 2S and Figure S4B, Supporting Information). Here, ADPGK is linked to neoplasm.